However, IL-6 receptors IL-6Rα and gp130 were found to be reduced on naïve CD4+ T cells from breast cancer patients compared to healthy donors by flow cytometry, and expression levels correlated with signaling responsiveness to IL-6, identifying a potential mechanism of impaired signaling (Fig. 2B). The gene discussed is CD4; the disease is breast carcinoma.